Last reviewed · How we verify

NCT03547570

Resistance Training for Patients With Hypermobility Spectrum Disorders and Shoulder Symptoms: a Feasibility Study

Completed NA Last updated 30 April 2021
What this trial tests

NA trial testing Progressive heavy shoulder resistance training in Hypermobility Syndrome Shoulder in 12 participants. Completed in 6 November 2018.

Timeline
4 May 2018
Primary endpoint
6 November 2018
6 November 2018

Quick facts

Lead sponsorUniversity of Southern Denmark
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment12
Start date4 May 2018
Primary completion6 November 2018
Estimated completion6 November 2018
Sites3 locations across Denmark

Drugs / interventions tested

Conditions studied

Sponsor

University of Southern Denmark

Who can join

Adults 18 to 65, any sex, with Hypermobility Syndrome Shoulder or Shoulder Pain Chronic. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Hypermobility Spectrum Disorders (HSD) is a recent diagnosis that covers joint hypermobility with one or more secondary symptomatic musculoskeletal manifestations. Current clinical management of this population with shoulder symptoms is a non-standardized combination of physiotherapy modalities including exercise prescription. There is evidence suggesting that progressive heavy resistance training increases muscle strength and tendon stiffness, which may be valuable for treatment of this population. The aim of this study is to evaluate the feasibility of progressive heavy shoulder resistance training (PHSRT) for adults with HSD and shoulder symptoms.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Heavy shoulder strengthening exercise in people with hypermobility spectrum disorder (HSD) and long-lasting shoulder symptoms: a feasibility study.
    Liaghat B, Skou ST, Jørgensen U, Sondergaard J, et al · · 2020 · cited 18× · PMID 32670599 · DOI 10.1186/s40814-020-00632-y

Verify or expand the search:

Other University of Southern Denmark trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03547570.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing